A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2018
At a glance
- Drugs Cisplatin (Primary) ; Paclitaxel (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 08 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 08 Jun 2016 Planned End Date changed from 1 Feb 2016 to 1 Dec 2017.
- 14 Feb 2013 Planned End Date changed from 1 Aug 2014 to 1 Feb 2016 as reported by ClinicalTrials.gov.